Notice2023-17999
Solicitation of Nominations for Membership To Serve on the Advisory Commission on Childhood Vaccines
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 22, 2023
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
HRSA is seeking nominations of qualified candidates for consideration for appointment as members of the Advisory Commission on Childhood Vaccines (ACCV). ACCV advises the Secretary of HHS (the Secretary) on issues related to the implementation of the National Vaccine Injury Compensation Program (VICP).
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 161 (Tuesday, August 22, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 161 (Tuesday, August 22, 2023)]
[Notices]
[Pages 57123-57124]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-17999]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Membership To Serve on the
Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations of qualified candidates for
consideration for appointment as members of the Advisory Commission on
Childhood Vaccines (ACCV). ACCV advises the Secretary of HHS (the
Secretary) on issues related to the implementation of the National
Vaccine Injury Compensation Program (VICP).
DATES: Written nominations for membership on the ACCV will be received
on a continuous basis.
ADDRESSES: Nomination packages must be submitted to the Director,
Division of Injury Compensation Programs, Health Systems Bureau, HRSA,
5600 Fishers Lane, Room 08N146B, Rockville, Maryland 20857. Electronic
nomination packages can be submitted by email to <a href="/cdn-cgi/l/email-protection#19585a5a4f59716b6a78377e766f"><span class="__cf_email__" data-cfemail="6d2c2e2e3b2d051f1e0c430a021b">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison,
Division of Injury Compensation Programs, Health Systems Bureau, HRSA
at 1-800-338-2382 or email at <a href="/cdn-cgi/l/email-protection#5a1b19190c1a3228293b743d352c"><span class="__cf_email__" data-cfemail="713032322731190302105f161e07">[email protected]</span></a>. A copy of the ACCV charter
and list of the current membership may be obtained by accessing the
ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/index.html">https://www.hrsa.gov/advisory-committees/vaccines/index.html</a>.
SUPPLEMENTARY INFORMATION: ACCV was established by title XXI of the
Public Health Service Act and advises the Secretary on issues related
to implementation of the VICP. ACCV meets four times per year and at
the call of the Chair.
Nominations: HRSA is requesting nominations for voting members to
serve as Special Government Employees (SGEs) on the ACCV to fill open
positions. The Secretary appoints ACCV members with the expertise
needed to
[[Page 57124]]
fulfill the duties of the Advisory Committee. The membership
requirements are set forth in section 2119 of the Public Health Service
Act.
ACCV consists of nine voting members appointed by the Secretary as
follows: (1) three health professionals, who are not employees of the
United States government, and who have expertise in the health care of
children, the epidemiology, etiology, and prevention of childhood
diseases, and the adverse reactions associated with vaccines, of whom
at least two shall be pediatricians; (2) three members from the general
public, of whom at least two shall be legal representatives (parents or
guardians) of children who have suffered a vaccine-related injury or
death; and (3) three attorneys, of whom at least one shall be an
attorney whose specialty includes representation of persons who have
suffered a vaccine-related injury or death, and of whom one shall be an
attorney whose specialty includes representation of vaccine
manufacturers. In addition, the Director of the National Institutes of
Health, the Assistant Secretary for Health, the Director of the Centers
for Disease Control and Prevention, and the Commissioner of the Food
and Drug Administration (or the designees of such officials) serve as
nonvoting ex officio members.
HHS will consider nominations of all qualified individuals to
ensure the ACCV includes the areas of subject matter expertise noted
above. As indicated above, at least two of the three ACCV members of
the general public must be legal representatives (parents or guardians)
of children who have suffered a vaccine-related injury or death.
Because those members must be the legal representatives of children who
have suffered a vaccine-related injury or death, to be considered for
appointment to the ACCV in that category, there must have been a
finding (i.e., a decision) by the U.S. Court of Federal Claims or a
civil court that a VICP-covered vaccine caused, or was presumed to have
caused, the represented child's injury or death. Additionally, based on
a recommendation made by ACCV, the Secretary will consider having a
health professional with expertise in obstetrics as one of the members
of the general public. Interested applicants may self-nominate or be
nominated by another individual or organization.
Individuals selected for appointment to ACCV will be invited to
serve for 3 years. Members are appointed as SGEs and receive a stipend
and reimbursement for per diem and travel expenses incurred for
attending ACCV meetings and/or conducting other business on behalf of
ACCV, as authorized by 5 U.S.C. 5703 for persons employed
intermittently in government service.
The following information must be included in the package of
materials submitted for each individual nominated for consideration:
(1) a letter of nomination stating the name, affiliation, and contact
information for the nominee, the basis for the nomination (i.e., what
specific attributes, perspectives, and/or skills does the individual
possess that would benefit the workings of the ACCV) and the nominee's
field(s) of expertise; (2) the name, address, daytime telephone number,
and email address at which the nominator can be contacted; and (3) a
current copy of the nominee's curriculum vitae or resume. Nomination
packages may be submitted directly by the individual being nominated or
by the person/organization recommending the candidate. Nomination
packages will be collected and retained to create a pool of possible
future ACCV voting members. When a vacancy occurs, nomination packages
from the appropriate category will be reviewed and nominees may be
contacted at that time.
HHS endeavors to ensure that ACCV's membership is balanced in terms
of points of view represented and that individuals from a broad
representation of geographic areas, gender, and ethnic and minority
groups, as well as individuals with disabilities, are considered for
membership. Appointments shall be made without discrimination on the
basis of age, disability, race, ethnicity, gender, sexual orientation,
national origin, or cultural, religious, or socioeconomic status.
Individuals who are selected to be considered for appointment will
be required to provide detailed information regarding their financial
holdings, consultancies, and research grants or contracts. Disclosure
of this information is required for HRSA ethics officials to determine
whether there is a potential conflict of interest between the SGE's
public duties as a member of ACCV and their private interests,
including an appearance of a loss of impartiality as defined by federal
laws and regulations, and to identify any required remedial action
needed to address the potential conflict.
Authority: Under the authorities that established the ACCV, the
Federal Advisory Committee Act of October 6, 1972, (Pub. L. 92-463, as
amended) and the National Childhood Vaccine Injury Act (Pub. L. 99-660,
as amended), HRSA is requesting nominations for voting members of ACCV.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-17999 Filed 8-21-23; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 22, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.